Thus, 2 cell lines were evaluated for proliferation inhibition: the NCI-N87 gastric cancer cell line, expressing high HER2 levels, and the MCF7 breast cancer cell line, expressing lower levels of HER2 (27). Here, ERBB2 is linked to breast carcinoma.